| scholarly article | Q13442814 |
| P50 | author | Benjamin Bowe | Q124325352 |
| Ziyad Al-Aly | Q40799081 | ||
| Yan Yan | Q42630474 | ||
| Yan Xie | Q64877558 | ||
| P2093 | author name string | Tingting Li | |
| Hong Xian | |||
| P2860 | cites work | Use of acid-suppressive drugs and risk of pneumonia: a systematic review and meta-analysis | Q22241389 |
| A new equation to estimate glomerular filtration rate | Q24651973 | ||
| Use of prescription and over-the-counter medications and dietary supplements among older adults in the United States | Q24657307 | ||
| Overprescribing proton pump inhibitors | Q24669995 | ||
| Association of Proton Pump Inhibitors With Risk of Dementia: A Pharmacoepidemiological Claims Data Analysis | Q28273381 | ||
| Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. | Q30353189 | ||
| Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. | Q30353195 | ||
| Doubly robust estimation of causal effects | Q30499313 | ||
| High-dimensional propensity score adjustment in studies of treatment effects using health care claims data | Q33457966 | ||
| Long-term kidney outcomes among users of proton pump inhibitors without intervening acute kidney injury | Q34048006 | ||
| Proton pump inhibitors and risk of fractures: a meta-analysis of 11 international studies | Q34186827 | ||
| A nationwide nested case-control study indicates an increased risk of acute interstitial nephritis with proton pump inhibitor use. | Q34285084 | ||
| Conflicting results between randomized trials and observational studies on the impact of proton pump inhibitors on cardiovascular events when coadministered with dual antiplatelet therapy: systematic review. | Q34458143 | ||
| Trends in Prescription Drug Use Among Adults in the United States From 1999-2012. | Q34500310 | ||
| Proton pump inhibitors and acute kidney injury: a nested case-control study | Q34833371 | ||
| Propensity score matching with time-dependent covariates | Q81145370 | ||
| Use of PPIs are not associated with mortality in institutionalized older people | Q84069378 | ||
| Failing the acid test: benefits of proton pump inhibitors may not justify the risks for many users | Q84198920 | ||
| Hypomagnesemia induced by several proton-pump inhibitors | Q84917288 | ||
| Use of proton pump inhibitors and mortality among institutionalized older people | Q85103495 | ||
| Proton pump inhibitors and risk of 1-year mortality and rehospitalization in older patients discharged from acute care hospitals | Q86270728 | ||
| Renal Function Trajectories in Patients with Prior Improved eGFR Slopes and Risk of Death | Q35930343 | ||
| Proton pump inhibitors and the risk of acute kidney injury in older patients: a population-based cohort study | Q36064989 | ||
| Long-term use of acid suppression started inappropriately during hospitalization | Q36120931 | ||
| Rate of Kidney Function Decline and Risk of Hospitalizations in Stage 3A CKD. | Q36250310 | ||
| Serum phosphorus levels and risk of incident dementia | Q36267683 | ||
| Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease | Q36635329 | ||
| Two-stage residual inclusion estimation: addressing endogeneity in health econometric modeling | Q36807244 | ||
| Proton pump inhibitor prescriptions and subsequent use in US veterans diagnosed with gastroesophageal reflux disease | Q36927372 | ||
| Proton Pump Inhibitors Accelerate Endothelial Senescence | Q36993998 | ||
| Proton pump inhibitors for prophylaxis of nosocomial upper gastrointestinal tract bleeding: effect of standardized guidelines on prescribing practice | Q37136712 | ||
| Overuse and inappropriate prescribing of proton pump inhibitors in patients with Clostridium difficile-associated disease | Q37138265 | ||
| Lifestyle factors among proton pump inhibitor users and nonusers: a cross-sectional study in a population-based setting | Q37378002 | ||
| Proton pump inhibitors and the risk of hospitalisation for community-acquired pneumonia: replicated cohort studies with meta-analysis | Q37658639 | ||
| Risk of Clostridium difficile infection with acid suppressing drugs and antibiotics: meta-analysis | Q38004673 | ||
| Heme oxygenase-1 and acute kidney injury | Q38166176 | ||
| Inhibition of lysosomal enzyme activities by proton pump inhibitors | Q39182584 | ||
| Beyond gastric acid reduction: proton pump inhibitors induce heme oxygenase-1 in gastric and endothelial cells | Q40277784 | ||
| High Density Lipoprotein Cholesterol and the Risk of All-Cause Mortality among U.S. Veterans | Q40625511 | ||
| Estimated GFR Trajectories of People Entering CKD Stage 4 and Subsequent Kidney Disease Outcomes and Mortality | Q40765535 | ||
| Proton pump inhibitors and hypomagnesemia in the general population: a population-based cohort study | Q40783849 | ||
| Proton Pump Inhibitors and Risk of Incident CKD and Progression to ESRD. | Q40799000 | ||
| Low levels of high-density lipoprotein cholesterol increase the risk of incident kidney disease and its progression | Q40882318 | ||
| Systematic toxicity mechanism analysis of proton pump inhibitors: an in silico study | Q41519798 | ||
| Immortal time bias in observational studies of drug effects | Q44123059 | ||
| Overuse of acid suppressant drugs in patients with chronic renal failure | Q44313396 | ||
| Proton-pump inhibitor use is associated with low serum magnesium concentrations | Q44522863 | ||
| Risk of death associated with use of PPIs in three cohorts of institutionalized older people in Finland | Q45256718 | ||
| Adverse Effects Associated With Proton Pump Inhibitors. | Q46014035 | ||
| Proton-pump inhibitor use and hip fractures in men: a population-based case-control study | Q46127661 | ||
| Geographic Variation and US County Characteristics Associated With Rapid Kidney Function Decline | Q47160640 | ||
| Reversing gears: discontinuing medication therapy to prevent adverse events | Q48505191 | ||
| Sensitivity analysis and external adjustment for unmeasured confounders in epidemiologic database studies of therapeutics. | Q52998393 | ||
| Proton-pump inhibitors and risk of fractures: an update meta-analysis. | Q55059359 | ||
| Less Is More | Q56459910 | ||
| Graphing survival curve estimates for time-dependent covariates | Q78595518 | ||
| Effect of proton pump inhibitors on hepatic regeneration | Q79755411 | ||
| P433 | issue | 6 | |
| P921 | main subject | United States of America | Q30 |
| veteran | Q193891 | ||
| P304 | page(s) | e015735 | |
| P577 | publication date | 2017-07-04 | |
| P1433 | published in | BMJ Open | Q17003470 |
| P1476 | title | Risk of death among users of Proton Pump Inhibitors: a longitudinal observational cohort study of United States veterans | |
| P478 | volume | 7 |
| Q93020272 | Acute exacerbation of chronic fibrosing interstitial pneumonia in patients receiving antifibrotic agents: incidence and risk factors from real-world experience |
| Q55493690 | Advantages and Disadvantages of Long-term Proton Pump Inhibitor Use. |
| Q95840700 | Association Between Proton Pump Inhibitors and Asthma: A Population-Based Cohort Study |
| Q57476362 | Association of Proton Pump Inhibitors With Hospitalization Risk in Children With Oropharyngeal Dysphagia |
| Q38610883 | Associations of Proton-Pump Inhibitors and H2 Receptor Antagonists with Chronic Kidney Disease: A Meta-Analysis |
| Q59705977 | Associations of ambient coarse particulate matter, nitrogen dioxide, and carbon monoxide with the risk of kidney disease: a cohort study |
| Q92710229 | Biomarkers for oralization during long-term proton pump inhibitor therapy predict survival in cirrhosis |
| Q64072690 | Blockade of Cardiac Proton Pump Impairs Ventricular Remodeling Through a Superoxide-DDAH-Dependent Pathway in Infarcted Rats |
| Q55242337 | Calculating reading ease score of patient package inserts in Iran. |
| Q58744190 | Chronic kidney disease (CKD) patients are exposed to more proton pump inhibitor (PPI)s compared to non-CKD patients |
| Q88108383 | Discontinuing Long-Term PPI Therapy: Why, With Whom, and How? |
| Q47137132 | Effects of genetic polymorphisms on the OCT1 and OCT2-mediated uptake of ranitidine. |
| Q92417285 | Estimates of all cause mortality and cause specific mortality associated with proton pump inhibitors among US veterans: cohort study |
| Q88873774 | Gastro-Oesophageal Reflux and Aspiration: Does Laparoscopic Fundoplication Significantly Decrease Pulmonary Aspiration? |
| Q94585480 | Impact of NPS MedicineWise general practitioner education programs and Choosing Wisely Australia recommendations on prescribing of proton pump inhibitors in Australia |
| Q47742865 | Intestinal Dysbiosis Secondary to Proton-Pump Inhibitor Use. |
| Q92824387 | Long-term Proton Pump Inhibitor Administration Caused Physiological and Microbiota Changes in Rats |
| Q91770629 | Long-term proton pump inhibitor usage and the association with pancreatic cancer in Sweden |
| Q55716567 | Maintenance use of non-steroidal anti-inflammatory drugs and risk of gastrointestinal cancer in a nationwide population-based cohort study in Sweden. |
| Q98281049 | No association between proton pump inhibitor use and ALS risk: a nationwide nested case-control study |
| Q47684124 | Particulate Matter Air Pollution and the Risk of Incident CKD and Progression to ESRD. |
| Q89855510 | Physicians' Perceptions of Proton Pump Inhibitor Risks and Recommendations to Discontinue: A National Survey |
| Q47351543 | Proton Pump Inhibitors and Dementia: Deciphering the Data |
| Q91698157 | Proton Pump Inhibitors and Risk of Acute and Chronic Kidney Disease: A Retrospective Cohort Study |
| Q54943564 | Proton Pump Inhibitors and Serum Magnesium Levels in Patients With Torsades de Pointes. |
| Q90205945 | Proton pump inhibitor use increases mortality and hepatic decompensation in liver cirrhosis |
| Q90330851 | Proton pump inhibitors and risk of liver cancer and mortality in patients with chronic liver disease: a systematic review and meta-analysis |
| Q55280841 | Proton pump inhibitors: from CYP2C19 pharmacogenetics to precision medicine. |
| Q90457613 | Sustained proton pump inhibitor deprescribing among dyspeptic patients in general practice: a return to self-management through a programme of education and alginate rescue therapy. A prospective interventional study |
| Q91862863 | The Association between the Use of Proton Pump Inhibitors and the Risk of Hypomagnesemia in a National Cohort of Veteran Patients with HIV |
| Q57116627 | The Emperor's New Clothes: a Critical Appraisal of Evidence-based Medicine |
| Q93272080 | The global and national burden of chronic kidney disease attributable to ambient fine particulate matter air pollution: a modelling study |
| Q90286841 | The risks of long-term use of proton pump inhibitors: a critical review |
| Q47998734 | We have had a gutful: The need for deprescribing proton pump inhibitors |
Search more.